# Insight vs SOMA

Insight records 2,761 monthly visits with -2.7% month-over-month growth and Free pricing. SOMA records 0 monthly visits with 0% growth and Freemium pricing.

| Metric | [Insight](https://openaitools.app/tool/insight) | [SOMA](https://openaitools.app/tool/soma) |
| :--- | :--- | :--- |
| Website URL | https://insightai.dev | https://soma.science |
| Categories | AI Research Tool, AI Healthcare, AI Assistant, AI Article Summarizer | AI Research Tool, AI Knowledge Graph, AI Healthcare, AI Productivity Tools |
| Pricing Model | Free | Freemium |
| Monthly Visits | 2,761 | 0 |
| MoM Growth Rate | -2.7% | 0% |
| Primary Market | United States | Global |
| Direct Visits | 1,088 | 0 |
| Review Score | 4.4 | 4.2 |
| Saved Count | 2 | 5 |
| Supported Platforms | Website | Website |

## Insight

Insight was created to remove one of the least rewarding parts of research: reading. Its PubMed feature searches across tens of millions of peer-reviewed biomedical articles, using language models to produce a one-click scientific summary instead of a list of citations to chase. Researchers can point it at a question and get a structured starting point within seconds.

Beyond summarization, the platform covers hypothesis generation and experimental design, exporting designs as a PDF report. It also integrates specialized data: MyVariant brings in hundreds of millions of human variants, MyGene covers millions of genes across tens of thousands of species, and NIH RePORTER and ClinicalTrials.gov supply insight into funded projects and ongoing or completed trials. A separate high-throughput discovery module aims at target, biomarker, and prognostic marker identification.

Insight is positioned as a free tool, with an optional donation channel to support the team. Its outputs are grounded in peer-reviewed sources, but the platform is a research accelerator rather than a clinical decision tool, so conclusions should still be validated by domain experts.

**Pricing & Plans:** Insight is free to use. The site asks visitors to try the tool and offers an optional donation link to support the mission; a waitlist exists for the high-throughput discovery module.

- **One-click scientific summaries:** Searches over 36 million peer-reviewed biomedical articles across roughly 30,000 journals and condenses findings into readable summaries.
- **Hypothesis generation:** Turns a research question into candidate hypotheses to explore, saving the blank-page phase of a study.
- **Experimental design export:** Drafts experimental designs that can be exported as a PDF report for review or planning.
- **Gene and variant data:** Integrates MyGene and MyVariant for gene and mutation lookups across millions of genes and human variants.
- **Grants and trials:** Connects NIH RePORTER and ClinicalTrials.gov so users can see funded projects and ongoing or completed clinical trials.

**Strengths:** Free to use with no cost barrier; Grounded in peer-reviewed and official biomedical data sources; Covers the full path from literature to hypothesis to design; Integrated gene, variant, trial, and grant data in one place

**Limitations:** AI-generated summaries still need expert verification before use; Some advanced discovery features are waitlisted; Interface is utilitarian and aimed at researchers rather than casual users

[Profile (Markdown)](https://openaitools.app/tool/insight.md)

## SOMA

SOMA tackles a familiar bottleneck in biomedical research: the volume of published studies grows faster than anyone can read, and the useful signal is scattered across thousands of papers that each describe one or two variables. SOMA ingests that literature, uses language models to extract the factors, exposures, biomarkers and conditions each study discusses, and records the relationships between them. The result is a graph you can navigate rather than a folder of PDFs you have to grep.

In practice, you start from a question — say, a medical condition or a lifestyle factor — and follow the graph outward. SOMA shows you which related factors have been studied in connection with it and, importantly, points back to the papers behind each link. That source linkage is what keeps the tool honest: the graph is a map of what the literature claims, and the underlying studies are still the evidence.

SOMA is aimed at researchers, analysts and students who need to get oriented in an unfamiliar corner of the biomedical literature quickly. It is a discovery and synthesis aid, not an oracle — its graphs surface candidate associations, and interpreting whether a link is causal, correlational or spurious remains a human job.

**Pricing & Plans:** SOMA is listed with a freemium model: a free entry point with paid plans for heavier use. Exact quotas and plan prices were not verifiable during this check — confirm current details on the official site.

- **Entity and relationship extraction:** SOMA parses published studies and pulls out the factors, exposures and outcomes they discuss, so you can examine the evidence base without reading every paper in full first.
- **Knowledge graph of biomedical findings:** Extracted relationships are organized into a connected graph, letting you start from one condition or factor and follow the links outward to related variables.
- **Source-linked evidence:** Each relationship in the graph is tied back to the studies that reported it, so you can open the source paper and judge the evidence yourself.
- **Question-driven exploration:** Search across study relationships to see which factors have been investigated together and where findings cluster or conflict.
- **Open literature focus:** Built around open-access biomedical literature, making large-scale literature review more tractable for teams and individual researchers.

**Strengths:** Turns scattered biomedical findings into an explorable graph; Cuts the time needed to orient in an unfamiliar research area; Links relationships back to the underlying source papers; Focused on open-access literature

**Limitations:** Site reliability issues — the public domain was unreachable during our checks; Coverage is strongest in biomedicine; other research domains are thinner; Extracted relationships and association graphs are hypotheses, not clinical proof; You still need domain expertise to interpret links and judge causality

[Profile (Markdown)](https://openaitools.app/tool/soma.md)

## Frequently Asked Questions

### How do Insight and SOMA compare in monthly traffic?

Insight has 2,761 monthly visits, while SOMA has 0. Traffic estimates describe audience size, not product quality.

### How do their growth rates compare?

Insight has a month-over-month growth rate of -2.7%; SOMA has 0%.

### How does pricing compare?

Insight: Free. Insight is free to use. The site asks visitors to try the tool and offers an optional donation link to support the mission; a waitlist exists for the high-throughput discovery module. SOMA: Freemium. SOMA is listed with a freemium model: a free entry point with paid plans for heavier use. Exact quotas and plan prices were not verifiable during this check — confirm current details on the official site.

## Alternatives

| # | Tool Name | Monthly Visits | MoM Growth Rate | Pricing Model | Summary | Profile (Markdown) |
| :--- | :--- | :--- | :--- | :--- | :--- | :--- |
| 1 | [Semantic Scholar](https://openaitools.app/tool/semantic-scholar) | 8,198,672 | +5.8% | Free | A free, AI-powered academic search engine for 240M+ papers across every scientific field | [.md](https://openaitools.app/tool/semantic-scholar.md) |
| 2 | [Consensus](https://openaitools.app/tool/consensus) | 6,014,388 | -1.2% | Freemium | AI academic search engine for peer-reviewed science | [.md](https://openaitools.app/tool/consensus.md) |
| 3 | [SciSpace](https://openaitools.app/tool/scispace) | 4,464,111 | +8.6% | Freemium | AI research platform for reading, understanding and writing scientific papers | [.md](https://openaitools.app/tool/scispace.md) |
| 4 | [Elicit](https://openaitools.app/tool/elicit) | 1,751,507 | +3.1% | Freemium | AI research assistant for evidence-based literature review and synthesis | [.md](https://openaitools.app/tool/elicit.md) |
| 5 | [Rayyan](https://openaitools.app/tool/rayyan) | 1,116,437 | +7.9% | Freemium | AI-assisted systematic review software for screening, extraction, and evidence synthesis at scale | [.md](https://openaitools.app/tool/rayyan.md) |
| 6 | [Scite](https://openaitools.app/tool/scite) | 841,974 | +1.1% | Free Trial, Contact for Pricing | AI answers grounded in 300M+ scholarly full texts | [.md](https://openaitools.app/tool/scite.md) |
| 7 | [ResearchRabbit](https://openaitools.app/tool/researchrabbit) | 831,571 | +3.1% | Free | Map the literature around the papers you love—free | [.md](https://openaitools.app/tool/researchrabbit.md) |
| 8 | [Connected Papers](https://openaitools.app/tool/connected-papers) | 750,576 | +3.1% | Freemium | Explore the academic literature as a visual graph of related papers | [.md](https://openaitools.app/tool/connected-papers.md) |
| 9 | [Dr.Oracle](https://openaitools.app/tool/dr-oracle) | 723,847 | -1.2% | Free Trial | Guideline-directed medical answers with citations, built for clinicians | [.md](https://openaitools.app/tool/dr-oracle.md) |
| 10 | [Paperguide](https://openaitools.app/tool/paperguide) | 371,972 | -2.9% | Freemium | AI-native workspace for literature reviews and auditable systematic reviews | [.md](https://openaitools.app/tool/paperguide.md) |

---
Source: https://openaitools.app/compare/insight-vs-soma

More Markdown: [Categories](https://openaitools.app/categories.md) · [Traffic rankings](https://openaitools.app/rankings.md) · [llms.txt](https://openaitools.app/llms.txt)
